Technology

Clinical Trial Imaging Technology From First Scan to Final Data

Clinical trial imaging does not succeed through software alone. It requires a controlled environment in which the protocol, imaging charter, clinical expertise and electronic record remain connected from study setup through final delivery.

Intrinsic Imaging uses validated technology to organize global image collection, protect participant privacy, identify acquisition problems, manage blinded central review and preserve the traceability of every assessment. Our specialists remain accountable at each decision point. Technology makes their work consistent, visible and reviewable.

The result is more than an image repository. It is an end-to-end operating framework built around the reliability of your imaging endpoints, the efficiency of participating sites and the evidence sponsors must defend during audit and regulatory review.

  • 3 FDA inspections

    Zero 483 observations

  • 5 BSI ISO certifications

    9001, 13485, 22301, 27001, 27018

  • 1000+ physicians

    Board-certified, fellowship-trained

One Controlled Imaging Record

Technology Across the Complete Trial Lifecycle

Technology is most valuable when every stage shares the same study logic. Select a stage to see how the configured system, imaging specialists and quality controls work together.

Stage 1 of 8

Study Design

Translate the protocol into a controlled imaging workflow before the first participant is scanned.

  • Study-specific imaging charter and acquisition requirements
  • Defined visits, modalities, assessments and response criteria
  • Configured roles, review sequence, adjudication rules and data outputs

Expert Oversight

Imaging specialists examine how each endpoint will be acquired, reviewed and delivered, then align the technical configuration with the approved study design.

Sponsor Value

A precise operating model reduces ambiguity at sites and gives every downstream system and team a common set of rules.

  1. Study Design: Translate the protocol into a controlled imaging workflow before the first participant is scanned. Technology controls: Study-specific imaging charter and acquisition requirements; Defined visits, modalities, assessments and response criteria; Configured roles, review sequence, adjudication rules and data outputs. Expert oversight: Imaging specialists examine how each endpoint will be acquired, reviewed and delivered, then align the technical configuration with the approved study design. Sponsor value: A precise operating model reduces ambiguity at sites and gives every downstream system and team a common set of rules.
  2. Site Setup: Prepare sites, scanners and technologists to produce consistent images across the trial network. Technology controls: Equipment surveys and scanner capability review; Protocol-specific acquisition parameters and test submissions; Phantom qualification where required by the study. Expert oversight: The project team reviews equipment readiness, training completion and qualification evidence before routine study imaging begins. Sponsor value: Early standardization limits avoidable variation between sites, scanner manufacturers and acquisition teams.
  3. Secure Image Intake: Receive imaging records through a controlled process that protects privacy and preserves traceability. Technology controls: Secure electronic image transfer and DICOM handling; De-identification controls for participant information; Assignment to the correct participant, visit and modality. Expert oversight: Exceptions in identifiers, expected content or submission context are resolved before an exam advances to clinical review. Sponsor value: A controlled intake process protects the chain of custody and keeps the image connected to the correct study timepoint.
  4. QC and Reconciliation: Check every submission against the imaging charter and reconcile the imaging record with study expectations. Technology controls: Protocol-based completeness and technical quality checks; Expected-versus-received exam tracking; Documented site queries, corrections and resubmissions. Expert oversight: Imaging personnel distinguish technical defects from protocol deviations and direct clear questions to the site when correction is possible. Sponsor value: Problems are addressed before they reach the reader or accumulate near an interim analysis or database lock.
  5. Central Review: Route qualified exams into a blinded, study-specific reading environment. Technology controls: Single-, double- and triple-read configurations; Role-based task assignment and blinded information display; Electronic assessment forms built around the charter. Expert oversight: Subspecialty physicians apply the defined criteria, measurement conventions and reviewer instructions for the clinical indication. Sponsor value: Structured review reduces interpretive variability while preserving reader independence and a reviewable assessment record.
  6. Quantitation and Adjudication: Apply quantitative methods and resolve reader disagreement without weakening the blind. Technology controls: Longitudinal measurements and imaging biomarker assessments; Study-specific discordance rules and adjudication routing; Traceable assessment versions and resolution outcomes. Expert oversight: Qualified analysts and adjudicators review the relevant images and evidence under the rules established for the trial. Sponsor value: The final imaging assessment reflects a controlled method rather than an informal reconciliation after the fact.
  7. Data Delivery: Convert completed imaging assessments into reconciled, sponsor-ready data and documentation. Technology controls: Controlled mappings, units, precision and transfer specifications; Reconciliation between source assessments and released datasets; Delivery packages prepared for analysis and regulatory review. Expert oversight: Project and data teams review completeness, resolved exceptions and release readiness before an authorized transfer. Sponsor value: Sponsors receive imaging data whose meaning can be traced from the delivered record back to the underlying assessment.
  8. Retention and Retrieval: Preserve the records and context needed for sponsor oversight, audit and inspection. Technology controls: Protected retention of images, assessments and essential metadata; Applicable audit trails and change history; Backup, recovery and accurate record-retrieval controls. Expert oversight: Access, retention and retrieval follow controlled procedures throughout the required record lifecycle. Sponsor value: The study record remains available and intelligible after active reading has ended.
01

Independent Assessment

How Blinded Central Review Protects Your Imaging Endpoints

A controlled review pathway keeps image quality, independent interpretation and endpoint resolution connected—without compromising reader blinding.

Site Images

Protocol-defined acquisition and secure submission.

Intake & Quality Control

Identity, completeness and acquisition checks.

Reader A

Independent, blinded assessment.

Reader B

Independent, blinded assessment.

Assessment Comparison

Apply the charter’s concordance and discordance rules.

Adjudication When Required

Resolve qualifying discordance; concordant assessments proceed directly to reconciliation.

Endpoint Data

Reconciled assessments and traceable data delivery.

Illustrative dual-reader pathway. The imaging charter defines the reader model, blinding rules, discordance criteria and when adjudication is required.

Purpose-Built Around the Study

The Technology Functions Behind Reliable Imaging Endpoints

Each function is configured to the protocol and governed within the same quality framework. This preserves clinical meaning as images move from the acquisition site to the final dataset.

Study Configuration

The protocol becomes a study-specific operating model: visits, modalities, acquisition rules, assessment forms, reader roles, adjudication logic and delivery specifications are defined before use.

Global Image Operations

Secure intake, DICOM handling, participant de-identification, visit assignment and protocol-based quality control organize imaging from geographically distributed clinical sites.

Central Reading Workflows

Technology supports blinded single-, double- and triple-read paradigms, independent review, adjudication and study-specific electronic assessments across imaging specialties.

Quantitative Imaging

Configured tools and controlled methods support lesion measurement, volumetric analysis, functional measures, imaging biomarkers and longitudinal comparisons appropriate to the endpoint.

Data Management

Identifiers, visits, image records, assessments and released results are reconciled across the workflow. Transfer specifications preserve content, units, precision and clinical meaning.

Quality and Validation

Intended-use validation, role-based access, audit trails, controlled change, recovery testing and record retention support reliable electronic records and inspection readiness.

Sponsor Command View

Know Where the Imaging Workstream Stands

Effective oversight requires more than a final report. Study reporting organizes the operational signals that reveal whether sites are submitting the right exams, quality issues are being resolved and central review is progressing toward delivery.

The exact measures, reporting cadence and data views are defined for each study.

Expected and Received

Track planned exams against submissions by participant, visit, site and modality.

Quality-Control Status

Distinguish accepted exams from submissions awaiting review, correction or resubmission.

Open Site Queries

Follow unresolved acquisition, identification and completeness questions to closure.

Reading Progress

Monitor assignment, completion and readiness across independent review stages.

Adjudication Status

Identify discordant assessments and follow required resolution without exposing blinded information.

Delivery Readiness

Review reconciliation and exception status before an authorized data release.

Built for Regulated Evidence

Data Integrity, Security and Continuity by Design

The controls behind the workflow matter as much as the visible features. Intrinsic Imaging connects intended-use validation with information security, cloud privacy and business continuity disciplines across the electronic record lifecycle.

Validated Intended Use

GAMP 5 principles and applicable FDA expectations guide requirements, risk-based verification, release and controlled change.

Access, Blinding and Audit Trails

Unique roles, study-specific visibility and reviewable histories protect accountability and independent assessment.

Information and Cloud Privacy

ISO 27001 and ISO 27018 controls govern information security and personally identifiable information in cloud environments.

Continuity and Recovery

ISO 22301 disciplines support continuity planning, protected records, backup, recovery and reliable retrieval.

Specialized Study Models

One Technology Framework, Configured for Different Evidence Questions

Drug and Biologic Trials

Configure acquisition and independent review around efficacy, safety and imaging biomarker endpoints from Phase I through Phase IV.

Explore imaging services

Medical Device Investigations

Support device placement, performance and safety assessments through controlled imaging workflows aligned with Class I, II and III development programs.

Explore medical device imaging

AI/CAD and MRMC Studies

Manage case datasets, reference standards, reader assignments, reading sessions and large observer-performance datasets within a controlled study environment.

Explore AI/CAD validation

Study Rescue and Transfer

Bring existing image archives, prior assessments and unresolved queries into a reconciled operating model without losing the history needed to interpret the record.

Explore study rescue

Technology Questions From Sponsors

Design the Technology Workflow Around Your Trial

We'll align imaging operations, review controls and data delivery with your protocol and endpoints.

Request a Proposal
  • 3 FDA inspections

    Zero 483 observations

  • 5 BSI ISO certifications

    9001, 13485, 22301, 27001, 27018

  • 1000+ physicians

    Board-certified, fellowship-trained